Home / Tag Archives: Diabetes care (page 3)

Tag Archives: Diabetes care

Diabetes and Hearing Loss: The Complication Many Clinicians Still Miss

Older man experiencing hearing difficulty beside a medical illustration of the inner ear and blood vessels linked to diabetes complications

Diabetes-related complications often bring to mind kidney disease, neuropathy, or vision problems. However, one complication continues to receive far less attention despite growing scientific concern: hearing loss linked to diabetes. Emerging evidence suggests that people with diabetes may face a significantly higher risk of hearing decline, yet routine auditory screening …

Read More »

The Rise of “Double Diabetes”: Why More Adults With Type 1 Diabetes Are Developing Insulin Resistance

Adult with type 1 diabetes checking blood sugar levels alongside obesity and insulin resistance health concepts

More adults living with type 1 diabetes are now developing obesity, insulin resistance, hypertension, and metabolic complications once linked mainly to type 2 diabetes. This growing overlap, often called double diabetes, is becoming a major concern for clinicians and patients alike. While insulin therapy remains essential for type 1 diabetes …

Read More »

Open-Source Diabetes Technology Is Entering the Mainstream: Are Clinicians Ready?

Clinician discussing open-source diabetes technology and DIY insulin automation with a patient using a continuous glucose monitor and insulin pump.

The conversation around DIY diabetes technology and patient-led insulin automation has changed dramatically over the past few years. What once existed on the margins of diabetes care is now gaining recognition from major medical organizations and healthcare providers. In fact, the 2026 American Diabetes Association (ADA) Standards of Care continue …

Read More »

Is Carb Counting Becoming Obsolete? The Rise of Precision Nutrition in Diabetes Care

Patient using continuous glucose monitoring alongside a healthy meal to support precision nutrition diabetes care and personalized blood sugar management.

A bowl of oatmeal can keep one person’s glucose stable while sending another person’s blood sugar sharply upward. The meal is identical, yet the metabolic response is completely different. That reality is pushing many clinicians to reconsider one of the most established principles in diabetes nutrition: carb counting. The growing …

Read More »

Diabetes Burnout Is Rising in the Age of Always-On Technology

Woman with diabetes appearing emotionally exhausted while using CGM and insulin technology amid digital health alerts and glucose monitoring devices

A glucose alarm goes off during dinner. Another alert appears at 2 a.m. A smartphone app flashes warnings about rising blood sugar before the day even starts. Diabetes technology promises better control, yet for some patients, the nonstop stream of notifications and health data can feel mentally exhausting. Clinicians are …

Read More »

Beyond the FIB-4: Why Diabetes Care Is Becoming a Hepatology-Endocrinology Partnership

Doctor reviewing advanced liver imaging and metabolic health data during diabetes fatty liver disease screening consultation

Screening for fatty liver disease in patients with diabetes is no longer limited to identifying elevated liver enzymes or calculating a fibrosis score during an annual visit. Instead, clinicians are entering an era where diabetes care and hepatology increasingly overlap, especially as metabolic dysfunction-associated steatotic liver disease, or MASLD, becomes …

Read More »

The FDA’s New Insulin Switching Rules: What Interchangeable Biosimilars Mean for Diabetes Care

Insulin pens beside an FDA symbol and prescription form representing interchangeable insulin biosimilars and pharmacy-level insulin switching in diabetes care.

A patient arrives at the pharmacy expecting their usual insulin refill, only to discover the box, brand name, and pen device suddenly look different. The pharmacist explains that the medication is an interchangeable biosimilar approved for automatic substitution. Although the insulin is considered clinically equivalent, the unexpected switch can still …

Read More »

Treatment Complexity in Type 2 Diabetes: When More Options Make Decisions Harder

Physician reviewing multiple Type 2 diabetes medications and treatment options during a patient care consultation

Managing Type 2 diabetes used to follow a relatively predictable path. Clinicians often started with metformin and added medications gradually as glucose control worsened. Today, however, diabetes care looks very different. The number of available therapies has expanded rapidly, and while that growth has improved patient outcomes, it has also …

Read More »

The Diabetes Diagnosis Gap: Are We Missing Patients Who Don’t Fit Classic Risk Profiles?

Doctor reviewing a patient for possible diabetes misdiagnosis using diagnostic tools in a clinical setting

Diabetes screening has improved over the last two decades, yet many patients still fall through the cracks. While clinicians often rely on traditional risk models that focus on obesity, age, family history, and sedentary lifestyle, not every patient with diabetes fits that familiar picture. As a result, many diabetes cases …

Read More »

When GLP-1 Therapy Plateaus: What Clinicians Should Do Next

Clinician reviewing patient progress during a GLP-1 plateau with metabolic trend chart on computer screen

Everything seems to be working perfectly until it suddenly isn’t. A patient is losing weight steadily, HbA1c levels are improving, and confidence is high during every follow-up visit. Then progress slows. The scale barely changes. Blood sugar readings stop improving. Patients start asking whether the medication has stopped working, while …

Read More »